Process development of a disease-modifying antirheumatic drug, TAK-603, based on optimization of Friedel-Crafts reaction and selective substitution of a triazole ring
Keywords: TAK-603; Friedel-Crafts reaction; Selective substitution; 1,2,4-Triazole;